Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 1 3Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 657Carcinoma, Renal Cell 384Carcinoma, Non-Small-Cell Lung 242Urinary Bladder Neoplasms 235Breast Neoplasms 221Melanoma 193Ovarian Neoplasms 191Neoplasms 178Colorectal Neoplasms 160Kidney Neoplasms 152Neoplasm Metastasis 131Carcinoma, Transitional Cell 126Pancreatic Neoplasms 124Lung Neoplasms 121Stomach Neoplasms 113Squamous Cell Carcinoma of Head and Neck 106Sarcoma 99Head and Neck Neoplasms 89Uterine Cervical Neoplasms 87Carcinoma, Hepatocellular 79Triple Negative Breast Neoplasms 75Esophageal Neoplasms 75Endometrial Neoplasms 74Colonic Neoplasms 64Wilms Tumor 56Small Cell Lung Carcinoma 54Carcinoma, Ovarian Epithelial 48Neuroblastoma 47Liver Neoplasms 46Testicular Neoplasms 45

Interventions

Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Advanced Prostate Cancer × Genitourinary × Clear all
NCT06369246 2026-03-09

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

M.D. Anderson Cancer Center

Phase 1 Recruiting
70 enrolled
Genitourinary

Advanced Prostate Cancer

NCT07115446 2025-12-05

Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer

Hansoh BioMedical R&D Company

Phase 1 Recruiting
63 enrolled
Genitourinary

Advanced Prostate Cancer

NCT05942001 2025-02-19

Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Recruiting
100 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡